GE HealthCare Technologies (GEHC) on Wednesday posted first-quarter results that came in better than analysts had expected, but the former General Electric division lowered its full-year profit outlook because of tariffs.

The medical device maker reported adjusted earnings per share of $1.01 on revenue that increased 3% year-over-year to $4.78 billion. Analysts polled by Visible Alpha had forecast $0.92 and $4.66 billion, respectively.

Adjusted EPS Forecast Lowered Due to $0.85-Per⛄-Shar꧟e Tariff Impact

However, GE HealthCar♊e lowered its full-year adjusted EPS forecast because of announced tariffs, which it said will have an impact of $0.85 per share. The company said it now expects adjusted EPS of $3.90 to $4.10, down from the prior range of $4.61 to $4.75. It still expects organic revenue growth of 2% to 3%.

"Regarding the current global trade environment, we are actively driving mitigation actions," CEO Peter Arduini said. "We continue to see strong customer demand in many of the markets we serve and are well-positioned to drive long-term value as we invest in future innovation."

Also on Wednesday, the company 🌳said꧅ its board has approved a stock buyback plan of up to $1 billion.

GE 🌸HealthCare shares rose 3% shortly after markets opened Wednesday. Entering the day, they had lost about 13% of their value sinc♚e the start of the year.

Last week, the firm's former corporate brethren 澳洲幸运5官方开奖结果体彩网:GE Vernova (GEV) and 澳洲幸运5官方开奖结果体彩网:GE Aerospace (GE) topped Q1 estimates and affirmed the💟ir full-year outlooks.

UPDATE—This article has been updated with the latest share price information.